Issue #11: When Exposure Outpaces Governance
Corporate innovation portfolios fail at the rhythm they are governed by, not at the rhythm they are run on.
This issue is Part 5 of a 6 issue arc on Corporate Venturing Under Constraint.
A corporate venture validates. The market signal is clear. Early commercial metrics move in the right direction. The team is engaged. The sponsor is talking about it in executive forums. And then, somewhere between the fourth and the seventh month after validation, momentum stalls.
The team has not changed. The market has not shifted. The product has not failed. The venture has done what it was set up to do. It has produced a signal that warrants commitment. And yet the commitment does not come. What looks like a venture losing momentum is most often a governance system that cannot keep pace with the cadence the portfolio’s exposure now requires.
A corporate innovation portfolio is rarely a single venture. It is a collection of internal builds, partnerships, minority investments, spin-outs, and acqui-hires, each carrying different exposure profiles and changing at different cadences. The single venture that stalls is the visible failure. The portfolio held inside the same governance system is the structural condition.
A note on scope. The argument here addresses corporate innovation portfolios that are actually executing innovation through one of the five vehicle types named above. Functions that wear an innovation label but operate as technology programmes, R&D rebrands, or transformation initiatives are a different organisational pattern.
The two rhythms operating at odds with each other.
An enterprise and its portfolio run on different rhythms, and many corporate governance systems are built to operate on only one of them.
The corporation runs on a calendar rhythm: quarterly reporting cycles, annual budget rounds, half-year reviews. Board cadence aligns with the listed company calendar, and capital allocation occurs in scheduled rounds. Decision rights are exercised at convened forums. Risk is assessed at periodic intervals. The rhythm is metronomic, and the instruments of governance are calibrated to it. They were built that way for good reason. A mature business produces predictable outputs, and the governance system that holds it can run on predictable cycles.
The portfolio runs on a different rhythm. Its exposure changes when signals change, and each vehicle in the portfolio carries a different exposure profile.
Internal builds carry exposure that compounds slowly and accelerates around validation. The cadence shifts from quarterly-acceptable to weekly-critical at the point the venture proves commercial signal.
Spin-outs carry exposure that concentrates around separation events. Decision rights, capital structure, and IP arrangements all become exposure-rich at moments when the parent’s governance system was not designed to handle on short notice.
Minority investments and corporate venture capital positions carry exposure driven by the portfolio companies and the broader funding environment. Follow-on rounds, down rounds, and bridge financings happen on the cadence of external markets. The parent’s standing capital review cycle cannot respond to the cadence external rounds require.
Partnerships carry exposure from counterparty behaviour. A partner reorganisation, a strategic shift, or a key personnel change can transform the partnership’s risk profile within a week. The governance instruments built for partnership review run on quarterly cycles at best.
Acqui-hires carry exposure in the integration window. Talent retention, integration scope, and IP harvesting decisions are high-exposure decisions for the first eighteen months. The parent’s standing M&A governance is built for the deal, not necessarily for the eighteen months after it.
Five vehicles.
Five exposure rhythms.
One governance system that runs on the corporation’s calendar.
When a corporate innovation portfolio is held within the parent’s governance system, every vehicle’s exposure rhythm must align with the parent’s calendar rhythm. The mismatch is not visible in early exploration because exposure is low and the governance system has time to respond. It becomes visible the moment any of the five vehicles generates exposure. Validation produces it for internal builds. Counterparty change produces it for partnerships. A follow-on round produces it for CVC positions. The trigger varies. The structural failure is the same, but exposure does not wait.
The enterprise runs on the calendar. The portfolio runs on the signal. Governance must run on the signal.
Three structural causes
Cause 1: Instruments calibrated to the parent’s reporting cycle
The first layer is the instruments themselves. The templates, the review forums, the approval forms, the risk registers, the business case formats. These are designed for steady-state business units that produce predictable data on predictable cycles.
When a venture is asked to operate within these instruments, it is expected to produce data that does not yet exist, at a cadence that does not match the rate at which the venture’s reality actually changes. The quarterly review requires an internal build to show variance against the forecast. The build has not been alive long enough for the forecast to be meaningful. The annual capital review asks a CVC team for a three-year fund return projection. The fund’s strongest current evidence is a follow-on round that closed last week. The partnership review asks for milestone progress against a contract written eighteen months ago. The contract no longer reflects either party’s reality. The instruments produce confidence in domains where the portfolio has none, and silence in the domains where the portfolio has a signal.
The governance system ends up reading a version of the portfolio that does not match the actual portfolio.
Cause 2: Decision rights held at the parent’s forums
Even if the instruments could be modified to carry venture-grade evidence, the authority to act on that evidence sits at forums that meet on the parent’s cadence. The quarterly executive committee, monthly steering group, half-yearly capital allocation board, or the annual strategic review.
A portfolio’s exposure can change in a week. The next forum that holds the relevant decision authority is six weeks away. By the time the decision is made, the exposure has shifted again, and the decision is responding to a state that no longer exists.
BCG’s 2024 survey of ~1,000 senior corporate executives on large-scale technology programmes found that two-thirds of those programmes fail to deliver on time, budget, or scope, with respondents identifying governance models that fail to empower teams to act between forums as one of the most common causes. The finding is not specific to innovation portfolios, but the mechanism is identical across them. When the authority to act on emerging conditions resides exclusively in scheduled forums, execution decays in the gap between them.
At portfolio scale, every vehicle’s exposure-driven decision has to wait.
A CVC follow-on opportunity that closes in nine days is held until the next capital committee.
A partnership that needs scope renegotiation after a counterparty change waits for the next review cycle.
An internal build that has been validated and now requires a step-change in capital and authority waits for the annual round.
The decision-makers are not the failure. The cadence at which they can convene is.
Cause 3: Capital allocation moves through processes designed for steady-state deployment
The slowest layer can often be capital. Even if the instruments carried the right evidence and the forums met on the right cadence, the capital itself cannot move at portfolio speed. Reallocations between cost centres require business case redevelopment. Off-cycle commitments need executive sponsorship that itself takes time to assemble. Movement between portfolio positions runs through finance processes calibrated for predictability, not responsiveness.
This is where exposure-responsive moves commonly fall short. A signal strengthens on an internal build. The diagnosis is correct. The instruments record it. The forum is willing to act. And the capital cannot be moved within the cadence the signal requires.
A partnership renegotiation becomes time-critical after a counterparty restructure. The capital committee meets in eight weeks. The window in which the renegotiation has leverage closes in twelve days. The position was lost not because the parent did not want it, but because the parent could not act on it in time.
The empirical picture on CVC longevity has two parts. Song Ma’s research, published in The Review of Financial Studies in 2020 and drawing on a long historical dataset, documented that the median life of a corporate venture capital division was approximately 4 years, with a mean of 6 years, compared with independent venture funds that run on 10- to 12-year cycles. More recent industry data from Global Corporate Venturing’s 2024 review suggests CVC longevity has been improving, with more than 60 per cent of tracked CVC units surviving beyond their first three years. The headline numbers have shifted; however, the mechanism behind closure has not.
The CVC units that closed in 2024 did so for reasons that confirm rather than contradict the original finding. Industry analysis, completed by Global Corporate Venturing’s 2024 review, of those closures is attributed to parent-company restructuring following share-price pressure, parent-company cost-cutting drives, takeover defence, and breakdowns in the relationship between the CVC and the parent’s core business. In each documented case, the CVC’s own portfolio performance was not the trigger. The triggers were parent-company dynamics operating on the parent’s calendar. Several units that had closed had been performing strongly by external rankings at the time of closure.
So the pattern holds, whether the median life is four years or longer, the vehicle is closed when the parent shifts, not when the venture work is done.
Capital allocated to corporate innovation is structurally short-tenure relative to the work it is being asked to do. Internal builds that require five-year horizons sit within governance frameworks that revisit allocation annually. CVC positions designed for ten-year cycles operate within parent vehicles whose continuation depends on the parent’s strategic mood. Acqui-hire integration windows of eighteen months sit within M&A governance that resets quarterly.
The willingness is there, but plumbing can be uplifted.
The three layers have a compounding effect.
Instrument failure produces a governance system that is blind to exposure.
A failure in decision rights results in a governance system that is slow to respond to exposure.
Capital failure produces a governance system that is structurally incapable of acting on exposure.
Where all three are present, the governance system observes the portfolio rather than governs it.
Why the challenge persists
The structural mismatch has been visible to senior corporate operators for at least a decade. BCG’s 2024 study explicitly notes that 10 years had passed since its 2015 large-scale study of the same pattern, with no measurable improvement over that period. The question is not whether the mismatch exists. The question is why corporations have not corrected it. There are two likely conditions that can explain the persistence.
The first is short-termism. Exposure-cadence governance is built to act on signals that pay out over timeframes longer than the parent can wait. A commit-harder move in response to a strengthening signal might require capital today and produce returns over three years. The capital is real but the return is unprovable. The governance system is held by people whose own incentives run on shorter cycles than the venture’s payout cycle. Patience is a cost the company has not been built to absorb, and exposure-responsive governance requires patience the parent lacks. The CVC closures 2024 take this shape. CVCs close when the parent comes under cost or strategic pressure, not when the CVC has completed its work. The vehicle’s calendar is set by the parents’ circumstances, not by the venture’s logic.
The second is the official permission. The instruments to act off-cycle exist nominally in many corporations. Board chairs can pull forward executive forums. CFOs can authorise off-cycle capital moves. Executives can order unscheduled portfolio reviews. They are also institutionally rationed. Using them off-cycle marks the user as undisciplined. Calling an executive committee six weeks in advance reads as poor planning. Moving capital outside the budget round reads as failure to forecast, triggering a portfolio review without a scheduled trigger reads as panic.
The CFO who can authorise an off-cycle capital move and does not is behaving rationally. The system is producing the behaviour it is designed to produce.
The governance system is structurally capable of exposure-cadence governance and institutionally constrained against it. The instruments are present. The willingness to use them is not. What appears to be cultural reluctance is, in fact, a rational response to institutional incentives. The individual operator bears the cost of using exposure-responsive governance. The portfolio bears the cost of not using it.
These two conditions do not cause the mismatch, but are part of the environment that makes it persistent.
Surfacing the governance-exposure mismatch
The first practical question is whether the mismatch exists in any given innovation portfolio and, if so, where it is concentrated. The diagnostic that follows surfaces the key items to consider when answering it. It can be run against a single venture or applied across a portfolio. For a single venture, each question tests one dimension of governance cadence for that venture. For a portfolio, the same questions are answered across all vehicles held, and the read is the aggregate. A portfolio that fails the diagnostic on internal builds but passes on CVC positions reveals where the structural mismatch is concentrated.
A governance system can be elegant on paper and structurally late in practice; this diagnostic seeks to test the latter.
Question 1. Does the next governance forum with the relevant authority convene before the next exposure change point for any vehicle in the portfolio?
Failure mode: Governance lag. The exposure changes before the forum meets. By the time decisions are made, the portfolio is responding to a state that no longer exists.
Question 2. Are the governance instruments asking questions each vehicle can answer with the data it currently produces?
Failure mode: Instrument mismatch. Vehicles are asked to produce data that does not yet exist, and are silenced in the domains where they have a real signal.
Question 3. Can capital be moved between portfolio positions within the cadence at which each vehicle’s exposure changes?
Failure mode: Capital paralysis. The reallocation lags the signal. By the time capital can move, the move is no longer the right one.
Question 4. Is there a named decision-maker for stop, scope-narrowing, and re-commitment moves between forums for each vehicle in the portfolio?
Failure mode: Authority gap. No one is empowered to act between scheduled meetings. Decisions accumulate informally and are never formally taken.
Question 5. Are the conditions that would trigger an off-cycle governance review defined in advance, with explicit thresholds for each vehicle?
Failure mode: Trigger absence. No defined event pulls governance forward. Off-cycle action depends on individual escalation, which is institutionally costly.
Question 6. When the portfolio’s exposure profile last changed materially, did governance respond within the same cycle, or in the next scheduled cycle?
Failure mode: Cadence drift. Governance always operates a beat behind exposure. The system is structurally late and has normalised the lag.
At a high level.
Six ‘yes’ answers could indicate a governance system operating at the exposure cadence. This is rare and worth examining for what is enabling it.
Three to five yes answers indicate a partial match. Governance responds to some exposure changes but not all of them. Established corporate innovation portfolios commonly sit here. The system works for the exposure changes it has been designed to anticipate, but fails for those it has not.
Two or fewer yes answers may indicate a structural mismatch. The parent’s calendar is governing the portfolio, not its own exposure. From this position, four predictable failure modes could follow.
Innovation theatre, where governance instruments record activity because activity is the only signal they can read. https://www.putideastowork.com/p/when-nothing-changes
Zombie pilots, where projects survive because the stopping authority cannot be exercised between forums. https://www.putideastowork.com/p/issue8-zombie-pilots
Portfolio drift, where reallocation cannot keep pace with the required cadence. https://www.putideastowork.com/p/issue-9-the-portfolio-illusion
Resource asymmetry, where capital flows lag signals of change. https://www.putideastowork.com/p/issue-10-resource-asymmetry
Looking for the exemption
Four arguments are commonly raised against the cadence-mismatch thesis, each of which carries some legitimacy. The size argument reflects real questions about portfolio scale. The stage argument reflects real concerns about premature formalisation. The separate-track argument reflects a structural response many corporations have actually made. The feature-not-bug argument reflects a financial discipline view that slow capital protects against overcommitment. The question is whether each one holds when tested against the rhythm at which the portfolio’s exposure actually moves.
“We have a separate governance track for innovation.”
The most common exemption. The corporation has designed an innovation committee, an innovation board, and an innovation steering group. The structure is new. The reader points to it as evidence that the problem has been solved.
The structure is new. The cadence is the same. A separate governance track that meets quarterly is still quarterly. The instrument was duplicated. The rhythm was not changed. If the innovation board meets every twelve weeks, exposure-cadence governance is still impossible. The track is decorative.
“Our portfolio is too small to need this level of discipline.”
The escape via size. The reader argues that exposure-cadence governance is for portfolios of scale. Their portfolio has three positions. The complexity does not warrant the discipline.
Size does not reduce the requirement. It concentrates it. A portfolio with three positions has more exposure per position than a portfolio with thirty. The cost of governance lag on a single position is higher, not lower, when the portfolio is small. The smaller the portfolio, the less it can afford the lag.
“We are at an early stage. Formal governance would slow us down.”
The escape via stage. The reader argues that exposure-cadence governance is for mature portfolios. Theirs is still exploratory. Formality would suppress the experimentation the portfolio currently needs.
Governance maturity is not a function of stage. It is a function of exposure. An early-stage internal build with a regulatory commitment carries real exposure. A first CVC position in a fast-moving sector carries real exposure. A partnership that signs a partnership agreement with a counterparty undergoing its own structural change carries real exposure. The exposure does not wait for the portfolio to feel mature enough to govern it. The stage is calendar-driven. Exposure is signal-driven. The conflation between the two is the trap.
“Slow capital is a feature, not a bug. It forces conviction before commitment.”
Sometimes in place for a rational reason initially, but a somewhat sophisticated exemption, and the one held most strongly across senior corporate leadership. The argument is that the parents’ slower capital cadence is a deliberate check on venture enthusiasm. Corporate ventures fail at high rates. Slowing capital movement forces the venture team to demonstrate conviction with evidence rather than urgency. The lag is in the governance.
The financial discipline tradition that underwrites this argument is one of the most valuable institutional safeguards corporations have. The structural argument here is not that the discipline is wrong. It is that the discipline is being applied to a cost it was not designed to address.
This argument has empirical weight on financial grounds and is worth taking seriously. A meta-analysis by Haslanger, Lehmann, and Seitz published in The Journal of Technology Transfer in 2023, synthesising 32 studies and more than 105,000 observations, found no significant relationship between CVC investments and financial performance. The CFO who is sceptical of CVC financial returns is reading the empirical literature correctly.
The same meta-analysis, however, also found that CVC investments are positively associated with strategic performance outcomes, such as patent citations and product introductions. The strategic value is real and measurable. The financial return is not. Which means the cost of governance lag in a CVC portfolio is not paid in lost financial returns. It is paid for a lost strategic position. The strategic position is the harder cost to see, because it does not appear on the next quarterly report. It eventually appears in a competitor’s product launch.
The same structure applies across the other four vehicle types. Slowing capital movement on an internal build does not preserve financial discipline. It surrenders the market window. Slowing down decisions on a partnership does not produce better counterparty negotiation. It cedes terms to the partner’s faster process. Slowing reallocation on an acqui-hire integration does not protect against integration risk. It guarantees talent attrition during the period when retention is most fragile.
The conviction-before-commitment argument confuses two different costs. Slow capital protects the parent from financial overcommitment. It does not protect the venture portfolio from strategic underperformance. The two are different decisions, and the governance system that mistakes one for the other is governing on the wrong dimension.
What to consider, if relevant.
The structural answer to the governance-cadence mismatch is a capability many corporations do not currently hold in the form the exposure cadence requires. That capability will take time to build, and it is the subject of the next issue. But the portfolio cannot wait for it. Four moves can be considered at the portfolio’s existing governance level, without redesigning standing instruments, that will close part of the gap.
These moves assume the portfolio is genuinely pursuing innovation and venture work that the company depends on. Where it is not, the structural pressure to make them does not exist.
Define off-cycle review triggers in advance. For each vehicle in the portfolio, name the conditions that would warrant pulling governance forward. A regulatory shift on a partnership. A down-round on a CVC position. A churn signal on an internal build’s pilot customers. A counterparty change on an acqui-hire integration. The point is not the list. The point is that the conditions are written down before they fire.
Pre-named triggers do two things the institutional system cannot otherwise accommodate. They convert off-cycle actions from individual escalation into institutional protocol, shifting the cost of acting from the individual operator to the system. The CFO who acts on a pre-named trigger is following the protocol, not breaching it. They also make the off-cycle move auditable in retrospect. The corporation that asks why an off-cycle review was triggered can be shown the document. Institutional permission constraints commonly dissolve when the action has a paper trail that predates the event.
The cost of not making this move: every off-cycle review depends on someone willing to spend personal capital to call it. In many quarters, no one is.
Name a single decision-maker between forums for each vehicle. Stop authority, scope-narrowing authority, and re-commitment authority should rest with a named person who does not have to wait for the next forum to act. This is not about creating a new role. It is about resolving an ambiguity left open by the existing governance structure.
In many corporate innovation portfolios, between-forum authority is held collectively, meaning no one person holds it. The portfolio lead can recommend a stop. The committee chair can endorse it. The capital committee has to confirm it. The actual decision floats between three people, none of whom has unilateral authority and all of whom can defer to the next meeting. Decisions accumulate in the gap. Some never resurface. Naming a single person with explicit authority converts a diffuse decision-rights problem into a clear escalation pathway. The named person does not need new powers; they need the authority they already have to be documented and unambiguous.
The cost of not making this move: between-forum decisions that should take minutes take six weeks, and many never get formally taken at all.
Pre-authorise reallocation thresholds with the capital committee. Have the conversation with the CFO or the capital committee chair about the size of reallocation that can be moved between portfolio positions without a new business case. Five hundred thousand. Two million. Whatever number the corporation can absorb without it triggering a full review. The number matters less than the threshold’s existence.
Corporations often already have an informal version of this. The CFO who quietly approves a small reallocation between two portfolio positions is exercising the discretion the role already carries. The problem is that discretion is rationed by institutional permission, which means it is used reluctantly and only when the operator is confident the move will not be questioned. Formalising the threshold converts ambiguous discretion into protocol. Protocol is cheap to use. Discretion is expensive. The same move that costs the CFO personal capital under the informal arrangement costs nothing under a documented threshold.
The cost of not making this move: every reallocation, however small, has to wait for the next capital committee, which compounds capital paralysis across the portfolio.
Audit the highest-exposure vehicle against the diagnostic before the next board cycle. Run the six questions against the vehicle in the portfolio carrying the most exposure right now. Not the whole portfolio. The single position with the highest exposure.
The reason to start narrow is structural. A portfolio-wide audit produces a long list of governance gaps, none of which has institutional urgency. A single-vehicle audit of the highest-exposure position produces a short list of urgent governance gaps. The conversation with the board changes from “we have governance debt across the portfolio” to “this specific position has these specific governance gaps before its next exposure event.” The first conversation is a strategy paper. The second is a decision the board has to make.
The cost of not making this move: the governance gap that will most likely lead to the next failure remains invisible until it blows up.
These are not the structural answers. The structural answer may require a capability that the corporation currently lacks or does not have the risk appetite for. But the cost of waiting for the structural answer while ignoring the operational moves is high. Each board cycle that passes with the mismatch in place compounds the cost.
A position is lost.
A pilot zombifies.
A signal goes unread.
The losses are not catastrophic in any single cycle.
They are continuous, and they accumulate.
If the parent’s standing instruments are designed for the calendar rhythm, and the failure modes traced above are downstream of that fact, then the parent’s standing capabilities cannot be the answer. The corporation’s existing functions are built for the rhythm the corporation runs on. They are structurally incapable of carrying the exposure-cadence work the portfolio requires. The instruments are not adequate. The forums do not meet often enough. The capital does not move fast enough. And no individual operator, however skilled, can carry out this work as a side responsibility alongside a role designed for steady-state oversight.
The capability needed is something the corporation has to build. What it looks like, how it sits within the corporate, and what discipline it requires are the subjects of what follows.
Closing out.
Governance does not mature with age. It matures with exposure.
This essay is based on the author's professional experience and interpretation of publicly available information. It is provided for general informational purposes only and does not constitute advice. Any views expressed are the author's own and do not refer to any specific organisation, program, or individual.
References & Further Reading
Ma, Song. “The Life Cycle of Corporate Venture Capital.” The Review of Financial Studies, Volume 33, Issue 1, January 2020, pages 358-394. Summary posted on the Harvard Law School Forum on Corporate Governance, 15 April 2019. Available at: https://corpgov.law.harvard.edu/2019/04/15/the-life-cycle-of-corporate-venture-capital/
Haslanger, Patrick, Erik E. Lehmann und Nikolaus Seitz. “The Performance Effects of Corporate Venture Capital: A Meta-Analysis.” The Journal of Technology Transfer, Volume 48, Issue 6, December 2023, pages 2132-2160. Open access. Available at: https://link.springer.com/article/10.1007/s10961-022-09954-w
Hurford, Stephen. “These CVC Units Didn’t Make It to 2025, and the Reasons Aren’t Always Easy to Understand.” Global Corporate Venturing, 19 December 2024. Available at: https://globalventuring.com/corporate/cvc-units-closed-2024/
Grebe, Michael, Vanessa Lyon, Michael Harnisch, Abhik Chatterjee, Steven Alexander Kok and Jon Brock. “Most Large-Scale Tech Programs Fail, Here’s How to Succeed.” Boston Consulting Group, 13 November 2024. Available at: https://www.bcg.com/publications/2024/most-large-scale-tech-programs-fail-how-to-succeed
Brock, Jon, Sesh Iyer, and Tamim Saleh. “Large-Scale IT Projects: From Nightmare to Value Creation.” Boston Consulting Group, 20 May 2015. Available at: https://www.bcg.com/publications/2015/technology-business-transformation-technology-organization-large-scale-it-projects